Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Morphine Antikörper (HRP)

ELISA Wirt: Kaninchen Polyclonal HRP
Produktnummer ABIN676802
  • Target Alle Morphine Produkte
    Morphine
    Reaktivität
    Bitte anfragen
    Wirt
    • 15
    • 4
    • 2
    • 1
    Kaninchen
    Klonalität
    • 15
    • 7
    Polyklonal
    Konjugat
    • 14
    • 3
    • 2
    • 1
    • 1
    • 1
    Dieser Morphine Antikörper ist konjugiert mit HRP
    Applikation
    • 20
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated Morphine
    Isotyp
    IgG
  • Applikationshinweise
    IHC-P 1:100-500
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    Gentamicin sulfate
    Vorsichtsmaßnahmen
    This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Target
    Morphine
    Abstract
    Morphine Produkte
    Substanzklasse
    Chemical
    Hintergrund

    Synonyms: Morphine 6.

    Background: Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.

Sie sind hier:
Kundenservice